Two novel adducts of formula Mn(hfac)2( NITPhCl )2 (1) and [Mn(hfac)2(IMHPhCl)]2(NIT-PhCl)·0.5H2O (2), where hfac = hexafluoroacetylacetonate, NITPhCl = 2-(3-chlorophenyl)-4,4,5,5-tetram-ethylimidazolyl-1-oxyl-3-oxide, IMHPhCl = 2-(3-chlorophenyl)-4, 4, 5, 5-tetramethylimidazolyl-3-oxide, have been prepared by the reaction of Mn(hfac)2·2H2O with NITPhCl. Compound 1 is triclinic, space group P-1with a = 1.3003(3) nm, 6 = 1.3138(3) nm,c = 1.4931 (3) nm, α = 83.74(3)°, β = 77.77(3)°, γ = 60.59(3)°, V=2.171(1)nm3, Z = 2. Compound 2 is triclinic, space group P-1 with a = 1.2994(3) nm, b = 1.4841(3) nm, c = 2.1031 (4) nm, a = 92.30(3)° ,p = 98.68(3)°, γ = 97.89(3)°, V= 3.964(2)nm3, Z = 2. Each manganese atom is hexacoordinated in both compounds and compound 2 is organized inchains by hydrogen bonds between neighboring pairs of NITPhCl and IMHPhCl.
<正> Two novel adducts of formula Mn(hfac)2( NITPhCl )2 (1) and [Mn(hfac)2(IMHPhCl)]2(NIT-PhCl)·0.5H2O (2), where hfac = hexafluoroacetylacetonate, NITPhCl = 2-(3-chlorophenyl)-4,4,5,5-tetram-ethylimidazolyl-1-oxyl-3-oxide, IMHPhCl = 2-(3-chlorophenyl)-4, 4, 5, 5-tetramethylimidazolyl-3-oxide, have been prepared by the reaction of Mn(hfac)2·2H2O with NITPhCl. Compound 1 is triclinic, space group P-1with a = 1.3003(3) nm, 6 = 1.3138(3) nm,c = 1.4931 (3) nm, α = 83.74(3)°, β = 77.77(3)°, γ = 60.59(3)°, V=2.171(1)nm3, Z = 2. Compound 2 is triclinic, space group P-1 with a = 1.2994(3) nm, b = 1.4841(3) nm, c = 2.1031 (4) nm, a = 92.30(3)° ,p = 98.68(3)°, γ = 97.89(3)°, V= 3.964(2)nm3, Z = 2. Each manganese atom is hexacoordinated in both compounds and compound 2 is organized inchains by hydrogen bonds between neighboring pairs of NITPhCl and IMHPhCl.